HIGHLIGHTS
- who: Lisette M. Harteveld MD from the a The Center for Congenital Heart Disease Amsterdam-Leiden, Leiden, The Netherlands have published the research work: 3-Month Enalapril Treatment in Pediatric Fontan Patients With Moderate to Good Systolic Ventricular Function, in the Journal: (JOURNAL)
- what: The authors evaluated the effect of ACE inhibition in pediatric Fontan patients with moderate-good systolic ventricular function and hypothesized that it may improve exercise performance and ventricular and vascular function. The authors aimed for a maximal enalapril dose of 0.5 mg/kg/day with a maximum of 20 mg . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.